Answers are grounded in this paper and cite their sources.
Impairments caused by stroke remain the main cause for adult disability. Despite a vigorous research effort, only 1 thrombolytic treatment has been approved in acute stroke (<3h). The limitations of preclinical studies and how these can be overcome have been the subject of various guidelines. However, often these guidelines focus on the acute stroke setting and omit long-term outcome measures, such as behaviour and neuroimaging. The considerations and practicalities of including the serial assessment of these approaches and their significance to establish therapeutic efficacy are discussed here.
No takes yet. Share an insight, caveat, or question.
Michel Modo (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: